GeNeuro
is a Switzerland-based biopharmaceutical company that researches and develops antibody therapies for the treatment of autoimmune and neurodegenerative diseases... Read moreGeNeuro
is a Switzerland-based biopharmaceutical company that researches and develops antibody therapies for the treatment of autoimmune and neurodegenerative diseases... Read more
News
Jan 28, 2025
FinanzNachrichten
GeNeuro: GeNeuro SA Announces Renewal of Provisional Debt-Restructuring Moratorium
Dec 06, 2024
FinanzNachrichten
GeNeuro: New Data Supporting a New Precision Medicine Approach for ALS Patients With GeNeuro's GNK-301 Presented at the 35th International Symposium on ALS/MND
Sep 30, 2024
FinanzNachrichten
GeNeuro: GeNeuro SA Obtains the Opening of Debt-Restructuring Proceedings
Sep 19, 2024
FinanzNachrichten
GeNeuro: GeNeuro: New Data Presented at the ECTRIMS 2025 Congress in Copenhagen Shows That Temelimab Rescues the Neurodegenerative Effects of HERV-W in an MS Model
Jul 10, 2024
StreetInsider
Press Release: GeNeuro : GeNeuro SA: End of the Liquidity Contract With GILBERT DUPONT
Jun 28, 2024
MarketScreener
GeNeuro: GeNeuro: failure of phase 2 study in Covid long
Jun 14, 2024
MarketScreener
GeNeuro: GeNeuro Announces Approval of all Resolutions Proposed at 2024 Annual General Meeting
May 29, 2024
MarketScreener
GeNeuro: Availability of documents and information for the annual shareholders' meeting of June 12, 2024
May 16, 2024
Yahoo
GeNeuro: GeNeuro Announces Last Patient Last Visit in its Post-COVID Trial and Confirms Top-Line Results by End of June 2024
May 02, 2024
MarketScreener
GeNeuro: GeNeuro Publishes its 2024 Universal Registration Document
GeNeuro Competitors
1
2
3
4
5
6
7
8
9
10